{"id":"https://openalex.org/W4400568448","doi":"https://doi.org/10.1111/cts.13852","title":"Dalzanemdor (SAGE\u2010718), a novel, investigational N\u2010methyl\u2010D\u2010aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose\u2010finding studies in healthy participants and an open\u2010label study in participants with Huntington's disease","display_name":"Dalzanemdor (SAGE\u2010718), a novel, investigational N\u2010methyl\u2010D\u2010aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose\u2010finding studies in healthy participants and an open\u2010label study in participants with Huntington's disease","publication_year":2024,"publication_date":"2024-07-01","ids":{"openalex":"https://openalex.org/W4400568448","doi":"https://doi.org/10.1111/cts.13852","pmid":"https://pubmed.ncbi.nlm.nih.gov/38988035","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11236904"},"language":"en","primary_location":{"id":"doi:10.1111/cts.13852","doi":"https://doi.org/10.1111/cts.13852","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13852","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13852","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13852","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068146736","display_name":"Aaron M. Koenig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Koenig","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042775579","display_name":"Michael Lewis","orcid":"https://orcid.org/0000-0002-4958-6634","observed_orcids":["https://orcid.org/0000-0002-4958-6634"]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Lewis","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070357961","display_name":"Jeffrey Wald","orcid":"https://orcid.org/0000-0002-7346-6755","observed_orcids":["https://orcid.org/0000-0002-7346-6755"]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeff Wald","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0002-7346-6755","affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024967597","display_name":"Sigui Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sigui Li","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053703769","display_name":"Mustafa Varoglu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mustafa Varoglu","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020410951","display_name":"Jing Dai","orcid":"https://orcid.org/0000-0002-9282-4052","observed_orcids":["https://orcid.org/0000-0002-9282-4052"]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Dai","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073452309","display_name":"Abdul J. Sankoh","orcid":"https://orcid.org/0009-0001-2618-0447","observed_orcids":["https://orcid.org/0009-0001-2618-0447"]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdul Sankoh","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005107114","display_name":"Katrina Paumier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katrina Paumier","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108402200","display_name":"James Doherty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Doherty","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]},{"author_position":"last","author":{"id":null,"display_name":"Mike Quirk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131505","display_name":"Sage Therapeutics (United States)","ror":"https://ror.org/03t9rxt77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131505"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mike Quirk","raw_affiliation_strings":["Sage Therapeutics, Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sage Therapeutics, Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4210131505"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5070357961"],"corresponding_institution_ids":["https://openalex.org/I4210131505"],"apc_list":{"value":3460,"currency":"USD","value_usd":3460},"apc_paid":{"value":3460,"currency":"USD","value_usd":3460},"fwci":1.8563,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.85464691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"17","issue":"7","first_page":"e13852","last_page":"e13852"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.5313000082969666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.5313000082969666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.11959999799728394,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.11429999768733978,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.718999981880188},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7369999885559082},{"id":"https://openalex.org/keywords/executive-function","display_name":"executive function","score":0.7950000166893005},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.6010000109672546},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.625},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8820000290870667}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8470498323440552},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6676409244537354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6668068170547485},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6558519601821899},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6238800287246704},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6009396314620972},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5846472978591919},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5688806176185608},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5165656805038452},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4256436824798584},{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.4207223057746887},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40682148933410645},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.367521196603775},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17320379614830017},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09784463047981262},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006816","descriptor_name":"Huntington Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/cts.13852","doi":"https://doi.org/10.1111/cts.13852","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13852","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13852","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11236904","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11236904","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11236904/pdf/CTS-17-e13852.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Transl Sci","raw_type":"Text"},{"id":"pmid:38988035","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38988035","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and translational science","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:39e2342313ec49e19d0b75707c08f91c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/39e2342313ec49e19d0b75707c08f91c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1111/cts.13852","doi":"https://doi.org/10.1111/cts.13852","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13852","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13852","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320315149","display_name":"Sage Therapeutics","ror":"https://ror.org/03t9rxt77"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400568448.pdf","grobid_xml":"https://content.openalex.org/works/W4400568448.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W71997661","https://openalex.org/W1507973104","https://openalex.org/W1861099460","https://openalex.org/W1965374102","https://openalex.org/W1979621741","https://openalex.org/W1986908032","https://openalex.org/W1992465104","https://openalex.org/W1996592124","https://openalex.org/W2035247878","https://openalex.org/W2037852973","https://openalex.org/W2050066016","https://openalex.org/W2052496080","https://openalex.org/W2073508793","https://openalex.org/W2102092558","https://openalex.org/W2107099794","https://openalex.org/W2128775004","https://openalex.org/W2141114982","https://openalex.org/W2167740291","https://openalex.org/W2486908111","https://openalex.org/W2808792262","https://openalex.org/W2912928642","https://openalex.org/W2966125432","https://openalex.org/W3011501504","https://openalex.org/W3045443729","https://openalex.org/W3090856971","https://openalex.org/W3158305723","https://openalex.org/W3174664487","https://openalex.org/W3190309334","https://openalex.org/W4224227502","https://openalex.org/W4281551813","https://openalex.org/W4283786331","https://openalex.org/W4316469866","https://openalex.org/W4382344384","https://openalex.org/W4386624510","https://openalex.org/W4389449927"],"related_works":["https://openalex.org/W4283786331","https://openalex.org/W4389447591","https://openalex.org/W2981124154","https://openalex.org/W4386624510","https://openalex.org/W2339657560","https://openalex.org/W3159845786","https://openalex.org/W4313200945","https://openalex.org/W4312088168","https://openalex.org/W2275901170","https://openalex.org/W4312222108"],"abstract_inverted_index":{"N-methyl-D-aspartate":[0],"receptor":[1],"(NMDAR)-positive":[2],"allosteric":[3],"modulators":[4],"(PAMs)":[5],"represent":[6],"a":[7,30,185],"potential":[8,39,234],"therapeutic":[9],"strategy":[10],"for":[11,37,136,232],"cognitive":[12,42,117,217,237],"impairment":[13,43,238],"in":[14,44,80,95,144,193,199,239],"disorders":[15,240],"associated":[16],"with":[17,124,206],"NMDAR":[18,33,242],"hypofunction,":[19],"including":[20],"Huntington's":[21],"disease":[22],"(HD)":[23],"and":[24,60,83,105,112,141,153,173,196],"Alzheimer's":[25],"disease.":[26],"Dalzanemdor":[27,119,131,202],"(SAGE-718)":[28],"is":[29],"novel,":[31],"investigational":[32],"PAM":[34],"being":[35],"evaluated":[36],"the":[38,57,154,233],"treatment":[40,235],"of":[41,63,221,230,236,241],"these":[45],"disorders.":[46],"We":[47],"report":[48],"first-in-human,":[49],"phase":[50],"I,":[51],"double-blind,":[52],"dose-finding":[53],"studies":[54],"to":[55,129,157],"assess":[56],"safety,":[58],"tolerability,":[59],"clinical":[61,228],"pharmacology":[62],"dalzanemdor.":[64],"A":[65,87],"single-ascending":[66],"dose":[67,89,170],"study":[68,90],"(dalzanemdor":[69,98],"0.35,":[70],"0.75,":[71],"1.5,":[72],"or":[73,100],"3.0":[74],"mg":[75,102],"vs.":[76,103],"placebo)":[77,104],"was":[78,93,120,150,162,188],"conducted":[79,94],"healthy":[81,96,145,194],"participants":[82,97,107,195],"included":[84,113],"food":[85],"effects.":[86],"multiple-ascending":[88],"(14":[91],"days)":[92],"0.5":[99],"1.0":[101,110],"HD":[106,200,209],"(open-label":[108],"dalzanemdor":[109,214,231],"mg)":[111],"exploratory":[114],"pharmacodynamics":[115],"on":[116,219],"performance.":[118],"generally":[121],"well":[122],"tolerated":[123],"no":[125],"adverse":[126],"events":[127],"leading":[128],"discontinuation.":[130],"exhibited":[132],"pharmacokinetic":[133],"parameters":[134],"appropriate":[135],"once-daily":[137],"dosing.":[138],"Following":[139],"single":[140,169],"multiple":[142,178,183],"doses":[143,179],"participants,":[146,210],"median":[147,155],"terminal":[148],"half-life":[149],"8-118":[151],"h,":[152],"time":[156],"reach":[158],"maximum":[159],"plasma":[160],"concentration":[161],"4-7":[163],"h.":[164],"Exposures":[165],"were":[166],"dose-proportional":[167,176],"after":[168,177,190],"(6-46":[171],"ng/mL)":[172],"more":[174],"than":[175],"(6-41":[180],"ng/mL).":[181],"With":[182],"dosing,":[184],"steady":[186],"state":[187],"achieved":[189],"11":[191],"days":[192,198],"13":[197],"participants.":[201],"exposure":[203],"decreased":[204],"slightly":[205],"food.":[207],"In":[208],"results":[211,225],"suggest":[212],"that":[213],"may":[215],"improve":[216],"performance":[218],"tests":[220],"executive":[222],"function.":[223],"These":[224],"support":[226],"continued":[227],"development":[229],"hypofunction.":[243]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-07-12T00:00:00"}